If; "Dow doesn't do research out in the open! The funding of university projects is just a way to be visible with young
scientists. It's a recruiting tool. Relax. Of course, Dow is doing QD R&D in-house to support a new growth business.
Whatever work they are doing to improve performance or reduce costs however, they certainly will not be talking about
until they commercialize it. (WRT process improvement trade secrets, they may never talk about it.) When Dow scientists
give talks at technical conferences it's typically in connection with fundamental research, technologies they aren't going
to commercialize (to throw off the competition), or to promote AFTER something has been commercialized. They use these
trips as attaboys and perks for prestige or CV building. In other words, they keep their cards close to their chest."
and N-co has a current mkt cap of 111.96M US.
It seems QMC's relationships would be of a similar nature.
Why do you think "we are getting closer to the point where $20MM buys 50% of the whole company, not just the JV in China"?
Do you think the GTG people were incompetent in vetting QMC?
Have you come across new information which leads you to believe this will be true?
